DrugPatentWatch Database Preview
Melphalan flufenamide hydrochloride - Generic Drug Details
What are the generic drug sources for melphalan flufenamide hydrochloride and what is the scope of patent protection?
Melphalan flufenamide hydrochloride
is the generic ingredient in one branded drug marketed by Oncopeptides Ab and is included in one NDA. There are five patents protecting this compound. Additional information is available in the individual branded drug profile pages.Melphalan flufenamide hydrochloride has ninety-three patent family members in twenty-seven countries.
There are twelve drug master file entries for melphalan flufenamide hydrochloride.
Summary for melphalan flufenamide hydrochloride
| International Patents: | 93 |
| US Patents: | 5 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Master File Entries: | 12 |
| Clinical Trials: | 3 |
| DailyMed Link: | melphalan flufenamide hydrochloride at DailyMed |
Recent Clinical Trials for melphalan flufenamide hydrochloride
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Oncopeptides AB | Phase 3 |
| Oncopeptides AB | Phase 2 |
| Oncopeptides AB | Phase 1/Phase 2 |
US Patents and Regulatory Information for melphalan flufenamide hydrochloride
International Patents for melphalan flufenamide hydrochloride
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Hong Kong | 1250492 | ⤷ Free Forever Trial |
| Australia | 2012247545 | ⤷ Free Forever Trial |
| Croatia | P20201300 | ⤷ Free Forever Trial |
| European Patent Office | 2928463 | ⤷ Free Forever Trial |
| China | 108685860 | ⤷ Free Forever Trial |
| Russian Federation | 2597154 | ⤷ Free Forever Trial |
| >Country | >Patent Number | >Estimated Expiration |
